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Massachusetts and Otolaryngology, Lahey Clinic, Burlington, MA 02114, USAReceived 9 November 2005; accepted 10 November 2005Summary Primary non-Hodgkin’s lymphoma (NHL) is rare. When it does occur, mandibular
NHL typically manifests similar to an odontogenic process. This results in delayed diagnosis
and treatment. We present a 53-year-old male who was erroneously treated for a dental pro-
cess for several months before the correct diagnosis of diffuse large B-cell lymphoma was
made. Fortunately, the solitary bony lymphoma had not disseminated and management by
chemo-radiation allowed for disease eradication and new, post-treatment, bone formation.
The purpose of this report is to describe a rare case of NHL of the mandible, explore the diag-
nosis and workup, and discuss treatment strategies.c 2005 Elsevier Ltd. All rights reserved.
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dIntroduction
Primary non-Hodgkin’s lymphoma (NHL) is found outside of
nodal tissues in 24–45% of cases.1,2 Common extranodal
sites include the GI tract, skin, and, less often, bone.1 In
the head and neck, Waldeyer’s ring, oral mucosa, salivary
glands, paranasal sinuses, laryngeal tissue, and osseous
structures have been found to exhibit primary NHL.3
The mandible accounts for only 0.6% of isolated malig-
nant non-Hodgkin’s lymphomas.4 When it does occur, man-
dibular NHL typically manifests similar to an odontogenic
process. This results in a delay in diagnosis. The purpose
of this report is to describe a rare case of NHL of the man-
dible, explore the diagnosis and workup, and discuss treat-
ment strategies.741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
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A 53-year-old male presented with a past history of vague
pain along his right mandible. He underwent extraction of
a mandibular molar tooth by an outside practitioner for a
presumed odontogenic process. Following extraction, his
symptoms stabilized and improved over the next three
months. He then began noting pain in the vicinity of the pre-
vious extraction site and right lower lip numbness devel-
oped. This was thought to be ‘‘osteomyelitis’’ or an
‘‘abscess’’ and he was treated with a course of antibiotics.
Subsequently, a fullness and fleshy mass was noted in the
buccal sulcus in the same region and progressively enlarged.
The area was biopsied and was found to be diffuse large B-
cell lymphoma with tumor cells positive for CD20, CD79a,
CD30, and Ki-1 (Fig. 1).
He was then referred for definitive management 10-
months following his initial extraction. Workup included
chest X-ray, CT scans (Fig. 2), PET scan (Fig. 3), bone scan,.
Figure 1 (A) Hematoxylin and eosin stain consistent with diffuse large B-cell lymphoma. (B) CD79A immunoperoxidase stain.
Figure 3 PET scan images showing the hyperintense right mandibular lesion.
Figure 2 CT scan demonstrating the osteolytic focus in the right mandible with buccal cortical erosion.
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was localized to the right mandible, without diffuse disease
or nodal involvement. He therefore was categorized as
stage IAE, primary mandibular NHL. It was the recommenda-
tion of oncologist that he undergo four cycles of CHOP Rit-
uxan followed by radiotherapy. He attained a complete
response and following therapy there appeared to be new
healthy bone formation.Discussion
NHL of bone is rare, representing only 5% of all extranodal
lymphomas.5 The cell architecture and histology is indistin-
guishable from nodal or lymphoid derived lymphomas.6
Intrabony lymphomas were first described by Parker and
Jackson.7 They arise from the medullary cavity and manifest
as a localized, solitary lesion. To be classified as a primary
NHL of bone there must be no evidence of visceral or lym-phatic involvement and no distant metastases for at least
6 months following diagnosis.8 Primary mandibular involve-
ment makes up about 5% of all NHL of bone and accounts for
8% all mandibular tumors.6
Malignant NHL of jaws affects adults in the 4th–5th dec-
ades with a male to female ratio of approximately 3:2,
although some reports suggest a female predilection.5,6
The clinical presentation of mandibular NHL usually involves
localized bone swelling, tooth resorption or mobility, mass
in an extraction socket, pain, pathologic fracture, and often
anesthesia or paresthesia along the distribution of the infe-
rior alveolar nerve.3,4,6,9–14 Paresthesia along the inferior
alveolar nerve distribution is common in NHL of the mandi-
ble with reports ranging from 20–100%.15
The diagnosis of NHL of the mandible is frequently de-
layed or erroneously diagnosed as dental disease because
the clinical presentation mirrors that of an odontogenic pro-
cess or localized osteomyelitis. There is an average elapse
of 10-weeks between initial presentation and diagnosis.11
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are usually that of non-specific osteolysis. Panoramic films
can show loss of cortical definition or widening of the man-
dibular canal, widening of the mental foramen, loss of lam-
ina dura, or widening of periodontal ligament.16 Buccal or
lingual cortical destruction is often found, but several re-
ports note that NHL of the mandible can manifest as an
extraosseous soft tissue mass with only minimal cortical
destruction observable on plain films.16
Typically, the symptoms continue to persist in the face
of attempted pharmacologic or dental therapies. This leads
most practitioners to take tissue for sampling and patho-
logic diagnosis. Histopathologic evaluation, together with
immunophenotypic and cytogenetic studies, elucidate the
pattern of involvement and histologic type. Diffuse large
B-cell lymphoma (formerly known as diffuse histiocytic lym-
phoma) is the most common subtype of NHL, including pri-
mary mandibular NHL.15,17
When tissue diagnosis confirms NHL of the mandible,
determination must be made regarding origination and
spread of the tumor. The work up should assess the extent
of disease and allow for accurate staging. Following clinical
examination and palpation of nodes, computed tomography
is essential to exclude visceral or nodal involvement. A skel-
etal survey is usually not warranted without the presence of
bone pain or related complaints. PET scanning is reported to
be comparable to CT and provides no additional information
than the typical work-up.18 Laboratory studies are typically
non-specific, although elevated lactate dehydrogenase is
observed as a poor prognostic factor.19
Staging takes into account the involved site and degree
of dissemination. Primary NHL of bone, as a single focus in
an extranodal site, is categorized as stage IE. For all-com-
ers, stage I NHL has a 5-year survival rate of 70% and the
median survival time for IE is 10 years.9 The 5-year survival
rate for stage IE NHL of the maxillo-mandibular region is re-
ported to be approximately 50%.9 Survival declines to 20%
and below for stages II–IV.
Treatment for primary lymphoma of the mandible typi-
cally consists of a combination of chemotherapy and radio-
therapy. It is important to note that radiologic appearance
does not always correlate with the true extent of the lesion.
The radiation field should incorporate the ipsilateral mandi-
ble and regional lymph. Radiation alone may be curative in
early lesions. Adjuvant chemotherapy is useful especially in
histopathologic variants suggesting aggressive behavior. The
role of surgery is for biopsy purposes and for the control of
persistent or recurrent local disease.
We present a case of isolated mandibular NHL, stage IE.
This is a rare condition but one that should be considered
when patients have persistent dental symptoms recalcitrant
to standard treatment. Fortunately, in this case, the soli-
tary bony lymphoma had not disseminated and management
by chemo-radiation allowed for disease eradication and
new, post-treatment, bone formation.References
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